Tags : Research

Sanofi and MD Anderson Sign a Five-Year Pact to Expedite

Shots: Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments, including targeted and immune-therapies for oncology patients. The alliance will support investigations into additional indications and combinations for studies already in the clinic The collaboration will integrate MD Anderson’s clinical trials infrastructure and Sanofi’s pipeline of investigational treatments to […]Read More

AbbVie Signs an Exclusive Research and Option to License Agreement

Shots: Sosei to receive ~$32M as upfront and ~$377M as option fees, development, and commercial milestones along with royalties on global sales of therapies. AbbVie to get an option to expand the collaboration up to a total of four therapies that modulate GPCR Sosei will leverage its StaR technology and GPCR-focused SBDD capabilities and fund […]Read More

BARDA to Fund $1B to AstraZeneca for Research and Development

Shots: The $1B support is for the development, production and delivery of the vaccine with its initiation in H2’20 including a P-III trial with 30,000 participants and a pediatric trial.AZ has initiated to provide wider access to University of Oxford’s vaccine and concluded to provide 400M doses has secured total manufacturing capacity for 1B doses […]Read More

Regeneron’s RGC Signs a Research Collaboration with Colorado Center to

Shots: RGC and CCPM to create genomics database of 450,000 DNA samples and corresponding health record from de- identified patients who participated in UCHealth system, and will sequence the DNA samples while producing genomic data which will facilitate translational medical research enabling treatment option for patients The focus of the collbaortaion is to pair the […]Read More

Johnson & Johnson and BARDA to Fund ~$1B in Research

Shots: The collaboration follows the existing partnership b/w J&J and BARDA while the company expects to initiate the clinical studies of selected vaccine candidates by Sept’2020 with the anticipated first batch of COVID-19 vaccine to be available for EUA in early 2021 Under the new agreement, J&J and BARDA to invest ~1B in research, development […]Read More

Bayer Signs a Research and License Agreement with Curadev to

Shots: Curadev to receive upfront, research funding, pre-clinical, clinical and commercial milestones of $266.9M along with royalties on sales. Bayer to gain exclusive access to novel molecules from Curadev, designed to inhibit the STING pathway The alliance focusses to discover new therapies targeting lung diseases, CV diseases and other inflammatory diseases. The collaboration will optimize […]Read More

uniQure Signs an Exclusive Research and License Agreement with Gen-X

Shots: uniQure has an option to acquire Gen-X to identify novel synthetic promoters to be use in gene therapy products, until the expiry of research collaboration The companies will exclusively work together to develop promoters utilizing SuRE technology for the uniQure’s research pipeline and will explore the further development of AAV vector libraries containing fragments […]Read More

GSK Signs a Research Collaboration with Clover for the Evaluation

Shots: GSK to provide pandemic adjuvant system to Clover to evaluate S-Trimer in preclinical studies while Clover has largest commercial-scale cGMP biomanufacturing capabilities in China involved in rapid scale-up and produce new coronavirus vaccine The focus of the collaboration is to evaluate the combination of GSK’s pandemic adjuvant system with Clover’s S-Trimer as a vaccine […]Read More